SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DYAX: Dyax Corp. -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (139)2/20/2007 8:22:30 PM
From: mcbio  Read Replies (1) | Respond to of 197
 
Why now? Why would Genzyme terminate now? Makes no sense to me. Phase III results are due in the second quarter I believe and, if positive, it would seem this drug is not too far from market. You would think GENZ would wait until AFTER the results to make this kind of decision (assuming the results are negative). Also, GENZ has to cough up $17 million. Anyways, I'm still long DYAX.



To: tuck who wrote (139)2/21/2007 1:39:15 AM
From: idos  Read Replies (1) | Respond to of 197
 
>Stock drifted lower all day, but doesn't seem to be moving after hours.<

I see it started a free fall of 15.7% AH and will probably fall even more. DYAX without the backing and experience of GENZ may drown. If Genzyme's act had nothing to do with DX88, then it was probably an ego issue which I despise. Dew's guess makes more sense though.
I still own some.
Edit: just noticed your post at the biotech firesales thread.

Best, ido


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News